Literature DB >> 8814465

The ongoing mystery of ARDS.

W A Knaus.   

Abstract

Mesh：

Year:  1996        PMID： 8814465     DOI： 10.1007/bf01708090

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  6 in total

Review 1.  The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination.

Authors:  G R Bernard; A Artigas; K L Brigham; J Carlet; K Falke; L Hudson; M Lamy; J R Legall; A Morris; R Spragg
Journal:  Am J Respir Crit Care Med       Date:  1994-03       Impact factor: 21.405

Review 2.  The prognosis of ARDS: appropriate optimism?

Authors:  F Lemaire
Journal:  Intensive Care Med       Date:  1996-05       Impact factor: 17.440

3.  Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Plasma IL-1 beta and IL-6 levels are consistent and efficient predictors of outcome over time.

Authors:  G U Meduri; S Headley; G Kohler; F Stentz; E Tolley; R Umberger; K Leeper
Journal:  Chest       Date:  1995-04       Impact factor: 9.410

4.  The acute respiratory distress syndrome: definitions, severity and clinical outcome. An analysis of 101 clinical investigations.

Authors:  P Krafft; P Fridrich; T Pernerstorfer; R D Fitzgerald; D Koc; B Schneider; A F Hammerle; H Steltzer
Journal:  Intensive Care Med       Date:  1996-06       Impact factor: 17.440

5.  Evaluation of definitions for adult respiratory distress syndrome.

Authors:  W A Knaus; X Sun; R B Hakim; D P Wagner
Journal:  Am J Respir Crit Care Med       Date:  1994-08       Impact factor: 21.405

6.  Improved survival of patients with acute respiratory distress syndrome (ARDS): 1983-1993.

Authors:  J A Milberg; D R Davis; K P Steinberg; L D Hudson
Journal:  JAMA       Date:  1995-01-25       Impact factor: 56.272
  6 in total
  1 in total

Review 1.  The use, and misuse, of exogenous endothelial-derived vasodilators in acute respiratory failure.

Authors:  A T Dinh-Xuan; F Brunet; J F Dhainaut
Journal:  Intensive Care Med       Date:  1997-11       Impact factor: 17.440
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.